TRAIL and Cardiovascular Disease—A Risk Factor or Risk Marker: A Systematic Review

TRAIL and Cardiovascular Disease—A Risk Factor or Risk Marker: A Systematic Review

Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) is a pro-apoptotic protein showing broad biological functions. Data from animal studies indicate that TRAIL may possibly contribute to the pathophysiology of cardiomyopathy, atherosclerosis, ischemic stroke and abdominal aortic aneurysm...

Full description

Bibliographic Details
Main Authors:	Katarzyna Kakareko, Alicja Rydzewska-Rosołowska, Edyta Zbroch, Tomasz Hryszko
Format:	Article
Language:	English
Published:	MDPI AG 2021-03-01
Series:	Journal of Clinical Medicine
Subjects:	TRAIL cardiovascular diseases cardiovascular risk cerebrovascular disorders apoptosis
Online Access:	https://www.mdpi.com/2077-0383/10/6/1252

Similar Items

Mid-Regional Proadrenomedullin as a New Biomarker of Kidney and Cardiovascular Diseases—Is It the Future?
by: Katarzyna Czajkowska, et al.
Published: (2021-02-01)

The Impact of Cardiovascular Risk Factors on the Course of COVID-19
by: Katarzyna Wilk-Sledziewska, et al.
Published: (2022-04-01)

The Links between Microbiome and Uremic Toxins in Acute Kidney Injury: Beyond Gut Feeling—A Systematic Review
by: Alicja Rydzewska-Rosołowska, et al.
Published: (2020-12-01)

An unexpected giant problem — Giant condyloma (Buschke–Lowenstein tumor)
by: Alicja Rydzewska-Rosołowska, et al.
Published: (2021-02-01)

Sirtuin 1 and Skin: Implications in Intrinsic and Extrinsic Aging—A Systematic Review
by: Angelika Bielach-Bazyluk, et al.
Published: (2021-04-01)

Preeclampsia-eclampsia and future cardiovascular risk among women in Taiwan
by: Yu-Ling Kuo, et al.
Published: (2018-06-01)

Trailing TRAIL Resistance: Novel Targets for TRAIL sensitization in Cancer cells
by: RACHANA eTRIVEDI, et al.
Published: (2015-04-01)

On Whether Ca-125 Is the Answer for Diagnosing Overhydration, Particularly in End-Stage Kidney Disease Patients—A Systematic Review
by: Barbara Emilia Nikitiuk, et al.
Published: (2024-02-01)

Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand (TRAIL) in Patients after Acute Stroke: Relation to Stroke Severity, Myocardial Injury, and Impact on Prognosis
by: Michal Mihalovic, et al.
Published: (2022-05-01)

Synchronous surgical treatment for brain and heart of cardiovascular and cerebrovascular diseases
by: SHI Ming⁃gang, et al.
Published: (2024-01-01)

The Interplay between Cardiovascular Risk, Cardiovascular Events, and Disease Activity in Primary Sjögren’s Syndrome: Is Uric Acid the Missing Link?
by: Alessia Alunno, et al.
Published: (2023-03-01)

More attention on synchronous intervention on cardiovascular and cerebrovascular diseases by neurosurgeon and card
by: TONG Xiao⁃guang, et al.
Published: (2024-01-01)

Locked Away—Prophylaxis and Management of Catheter Related Thrombosis in Hemodialysis
by: Joanna Szymańska, et al.
Published: (2021-05-01)

Show Me What You Have Inside—The Complex Interplay between SIBO and Multiple Medical Conditions—A Systematic Review
by: Natalia Sroka, et al.
Published: (2022-12-01)

Cannabis use disorder and the future risk of cardiovascular disease in parous women: a longitudinal cohort study
by: Nathalie Auger, et al.
Published: (2020-11-01)

Antipsychotics and Risks of Cardiovascular and Cerebrovascular Diseases and Mortality in Dwelling Community Older Adults
by: Sylvie Perreault, et al.
Published: (2024-01-01)

HTNV Sensitizes Host Toward TRAIL-Mediated Apoptosis—A Pivotal Anti-hantaviral Role of TRAIL
by: Qing-Zhou Chen, et al.
Published: (2020-06-01)

Overcoming TRAIL Resistance for Glioblastoma Treatment
by: Longfei Deng, et al.
Published: (2021-04-01)

Urban trails : a preliminary list of trails and sources/
by: 409605 Goodey, Brian
Published: (1974)

Cytotoxic Efficacy and Resistance Mechanism of a TRAIL and VEGFA-Peptide Fusion Protein in Colorectal Cancer Models
by: Michal Kopczynski, et al.
Published: (2021-03-01)

Alternative functions for TRAIL receptors in eosinophils and neutrophils
by: I Daigle
Published: (2001-05-01)

Endogenous TRAIL-R4 critically impacts apoptotic and non-apoptotic TRAIL-induced signaling in cancer cells
by: Anna-Christina Rambow, et al.
Published: (2022-09-01)

Fabry disease – what a gastroenterologist should know
by: Alicja Rydzewska-Rosołowska, et al.
Published: (2023-12-01)

TRAIL and curcumin codelivery nanoparticles enhance TRAIL-induced apoptosis through upregulation of death receptors
by: Xi Yang, et al.
Published: (2017-01-01)

Mammographic Screening as a Tool for Cardiovascular Risk Assessing. Part 2. Association of Breast Arterial Calcification and Cardiovascular Diseases
by: E. V. Bochkareva, et al.
Published: (2019-07-01)

Assessment of Dietary Habits Using the Diet Quality Index—International in Cerebrovascular and Cardiovascular Disease Patients
by: In Young Cho, et al.
Published: (2021-02-01)

The regulation of combined treatment-induced cell death with recombinant TRAIL and bortezomib through TRAIL signaling in TRAIL-resistant cells
by: Sunhyo Ryu, et al.
Published: (2018-04-01)

Planning for urban trails/
by: 8697 American Society of Planning Officials, et al.
Published: (1969)

The Impact of Air Pollution on Hospitalization for Cardiovascular and Cerebrovascular Disease in Shenyang, China
by: Qingquan REN, et al.
Published: (2020-07-01)

The Role of TRAIL in Apoptosis and Immunosurveillance in Cancer
by: Julio M. Pimentel, et al.
Published: (2023-05-01)

Upregulation of endogenous TRAIL-elicited apoptosis is essential for metformin-mediated antitumor activity against TNBC and NSCLC
by: Shuang Liu, et al.
Published: (2021-06-01)

Traals for the twenty-first century : planning, design, and managemant manual for multi use-trails /
by: Ryan, Karen-Lee
Published: (1993)

The Impact of TRAIL on the Immunological Milieu during the Early Stage of Abdominal Sepsis
by: Ann-Kathrin Berg, et al.
Published: (2023-03-01)

Tumor Therapy Mediated by Lentiviral Expression of shBcl-2 and S-TRAIL
by: Norman Kock, et al.
Published: (2007-05-01)

Assessment of concentrations of sTRAIL ligand and its receptors sTRAIL-R1 and sTRAIL-R2 – markers monitoring the course of the extrinsic pathway of apoptosis induction: potential application in ovarian cancer diagnostics
by: Aleksandra Mielczarek-Palacz, et al.
Published: (2015-11-01)

Prevention and management strategies of cardiovascular and cerebrovascular comorbidity
by: WANG Pei⁃jian, et al.
Published: (2024-02-01)

Changes in the Concentration of Markers Participating in the Regulation of the Apoptosis Receptor Pathway Involving Soluble Tumour Necrosis Factor Ligand inducing Apoptosis (sTRAIL) and Osteoprotegerin (OPG) in the Serum of Women with Ovarian Cancer—Participation in Pathogenesis or a Possible Clinical Use?
by: Aleksandra Mielczarek-Palacz, et al.
Published: (2020-03-01)

The Serum Concentration of Anti-Aging Proteins, Sirtuin1 and αKlotho in Patients with End-Stage Kidney Disease on Maintenance Hemodialysis
by: Zbroch E, et al.
Published: (2020-03-01)

Marine Actinomycetes-Derived Secondary Metabolites Overcome TRAIL-Resistance via the Intrinsic Pathway through Downregulation of Survivin and XIAP
by: Mohammed I. Y. Elmallah, et al.
Published: (2020-07-01)

Importance of TRAIL Molecular Anatomy in Receptor Oligomerization and Signaling. Implications for Cancer Therapy
by: Javier Naval, et al.
Published: (2019-03-01)